Crosstalk-free signal source for dense wavelength division multiplexed systems
First Claim
1. An optical device for reducing crosstalk associated with a plurality of optical channels in a communication system comprising:
- a light source for generating a light signal at a particular wavelength, said light source having a ramp-up period in which said light source does not substantially emit the light signal at the particular wavelength; and
a light modulation element coupled to said light source, said light modulation element having an “
on” and
“
off”
state such that when said light modulation element is in said “
on”
state, said light signal generated by said light source at said particular wavelength is substantially allowed to propagate along an optical transmission path, and when said light modulation element is in said “
off”
state, said light modulation element substantially prevents said light signal from propagating along said optical transmission path, said light modulation element being in the off state during the ramp-up period of said light source to substantially prevent the light signal at a wavelength other than the particular wavelength from propagating along said optical transmission path.
6 Assignments
0 Petitions

Accused Products

Abstract
An optical device is provided which locks the wavelength output of a laser transmitter in an optical transmission system as well as preventing the propagation of unwanted signals generated by the laser transmitter prior to the transmitter reaching the desired operating wavelength thereby reducing crosstalk between channels within a wavelength division multiplexed communication system.
262 Citations
Analyte monitoring device and methods of use | ||
Patent #
US 7,885,699 B2
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,914,450 B2
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,905,833 B2
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,869,853 B1
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,955,261 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,933,639 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and method | ||
Patent #
US 7,920,907 B2
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 7,920,906 B2
Filed 03/09/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,925,321 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,959,569 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,935,057 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 7,927,274 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,010,174 B2
Filed 08/22/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 7,976,778 B2
Filed 06/22/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,998,071 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,005,525 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,000,901 B2
Filed 08/09/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,986,986 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,005,524 B2
Filed 03/24/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 7,976,492 B2
Filed 08/06/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,979,104 B2
Filed 05/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,052,601 B2
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,060,173 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,860,544 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT | ||
Patent #
US 20100261987A1
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,774,145 B2
Filed 01/18/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,826,981 B2
Filed 01/18/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Implantable analyte sensor | ||
Patent #
US 7,657,297 B2
Filed 05/03/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,797,028 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 7,783,333 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,778,680 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 7,857,760 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20090124877A1
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Circuitry for optimization of power consumption in a system employling multiple electronic components, one of which is always powered on | ||
Patent #
US 20090138739A1
Filed 11/19/2008
|
Current Assignee
Medos International Sarl
|
Original Assignee
Codman Neuro Sciences Sarl
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,583,990 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,599,726 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Composite material for implantable device | ||
Patent #
US 7,637,868 B2
Filed 01/11/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Bandwidth enhanced self-injection locked DFB laser with narrow linewidth | ||
Patent #
US 7,346,083 B2
Filed 04/10/2001
|
Current Assignee
HRL Laboratories LLC
|
Original Assignee
HRL Laboratories LLC
|
Method and apparatus for measuring electro-physiological activity | ||
Patent #
US 7,447,534 B1
Filed 03/21/2005
|
Current Assignee
Srico Incorporated
|
Original Assignee
Srico Incorporated
|
Circuitry for optimization of power consumption in a system employing multiple electronic components, one of which is always powered on | ||
Patent #
US 7,472,301 B2
Filed 05/27/2005
|
Current Assignee
Medos International Sarl
|
Original Assignee
Codman Neuro Sciences Sarl
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,276,029 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Multifunction optical transmitter for DWDM system | ||
Patent #
US 6,563,846 B1
Filed 09/06/2000
|
Current Assignee
Level 3 Communications LLC
|
Original Assignee
Corvita Corporation
|
Optical communication system | ||
Patent #
US 7,062,170 B2
Filed 08/12/2002
|
Current Assignee
Sony Corporation
|
Original Assignee
Sony Corporation
|
Circuitry for optimization of power consumption in a system employing multiple electronic components, one of which is always powered on | ||
Patent #
US 20060271797A1
Filed 05/27/2005
|
Current Assignee
Medos International Sarl
|
Original Assignee
Codman Neuro Sciences Sarl
|
System and methods for processing analyte sensor data | ||
Patent #
US 20050027181A1
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 20050027462A1
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 6,931,327 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
IMPLANTABLE ANALYTE SENSOR | ||
Patent #
US 20050245795A1
Filed 05/03/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optical communication system | ||
Patent #
US 20030039002A1
Filed 08/12/2002
|
Current Assignee
Sony Corporation
|
Original Assignee
Sony Corporation
|
Bandwidth enhanced self-injection locked DFB laser with narrow linewidth | ||
Patent #
US 20020163941A1
Filed 04/10/2001
|
Current Assignee
HRL Laboratories LLC
|
Original Assignee
HRL Laboratories LLC
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,519 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,520 B2
Filed 05/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,128,562 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,150,488 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,160,669 B2
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,160,671 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,167,801 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,195,265 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,206,297 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,216,139 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,229,536 B2
Filed 05/27/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,233,959 B2
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,233,958 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,236,242 B2
Filed 02/12/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,249,684 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,251,906 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,257,259 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal data artifacts in a glucose sensor data stream | ||
Patent #
US 8,260,393 B2
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,265,725 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,268,243 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,275,437 B2
Filed 03/23/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 8,282,550 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,282,549 B2
Filed 12/08/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,285,354 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,287,453 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,290,561 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,290,562 B2
Filed 05/03/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,292,810 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,311,749 B2
Filed 05/26/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,321,149 B2
Filed 06/29/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,332,008 B2
Filed 03/23/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,346,338 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,369,919 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,374,667 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,386,004 B2
Filed 09/07/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,394,021 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,412,301 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,423,113 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,428,678 B2
Filed 05/16/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,428,679 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,435,179 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,442,610 B2
Filed 08/21/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,463,350 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,469,886 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,491,474 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,516 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,548,551 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,548,553 B2
Filed 06/22/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,560,037 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,849 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 8,562,558 B2
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,571,625 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,579,816 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,588,882 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,611,978 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,622,905 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,657,745 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,657,747 B2
Filed 04/05/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,672,845 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,676,287 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,700,117 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,747,315 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,761,856 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 8,765,059 B2
Filed 10/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,771,187 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,774,888 B2
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,777,853 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,006 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,008 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,788,007 B2
Filed 03/08/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,790,260 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,954 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,795,177 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,801,612 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,801,610 B2
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,808,182 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,812,073 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,821,400 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,825,127 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,843,187 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,273 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,915,849 B2
Filed 02/03/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,986,209 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,060,742 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,078,608 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,107,623 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,149,219 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,192,328 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Circuitry for optimization of power consumption in a system employling multiple electronic components, one of which is always powered on | ||
Patent #
US 9,201,484 B2
Filed 11/19/2008
|
Current Assignee
Medos International Sarl
|
Original Assignee
Codman Neuro Sciences Sarl
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,220,449 B2
Filed 07/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,282,925 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,314,196 B2
Filed 09/07/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,351,668 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,364,173 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,420,965 B2
Filed 07/01/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,420,968 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,427,183 B2
Filed 07/12/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 9,446,194 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,451,908 B2
Filed 12/19/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 9,477,811 B2
Filed 06/23/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,498,155 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,510,782 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 9,538,946 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,585,607 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,649,069 B2
Filed 06/29/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,724,045 B1
Filed 04/06/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 9,741,139 B2
Filed 08/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,750,441 B2
Filed 08/15/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,750,460 B2
Filed 04/14/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,801,572 B2
Filed 06/18/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 9,895,089 B2
Filed 05/20/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,918,668 B2
Filed 03/09/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 10,349,873 B2
Filed 04/27/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 10,403,012 B2
Filed 07/18/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,524,703 B2
Filed 01/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,537,678 B2
Filed 12/16/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,137 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,136 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,135 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,610,642 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,617,336 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,653,835 B2
Filed 10/24/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for simulating glucose response to simulated actions | ||
Patent #
US 10,675,405 B2
Filed 12/04/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,709,364 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,362 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,363 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,716,498 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,722,152 B2
Filed 11/05/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,743,801 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 10,786,185 B2
Filed 01/05/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,158 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,159 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,577 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,576 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,835,672 B2
Filed 05/05/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,856,787 B2
Filed 07/31/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,898,114 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 10,898,113 B2
Filed 06/05/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
WDM optical communication systems with wavelength-stabilized optical selectors | ||
Patent #
US 6,111,681 A
Filed 05/08/1997
|
Current Assignee
Ciena Corporation
|
Original Assignee
Ciena Corporation
|
Optical modulators as monolithically integrated optical isolators | ||
Patent #
US 5,663,824 A
Filed 11/02/1993
|
Current Assignee
International Business Machines Corporation
|
Original Assignee
Lucent Technologies Inc.
|
Laser wavelength control device | ||
Patent #
US 5,943,152 A
Filed 05/08/1997
|
Current Assignee
Ciena Corporation
|
Original Assignee
Ciena Corporation
|
Light absorption modulator and integrated semiconductor laser and modulator | ||
Patent #
US 5,771,257 A
Filed 12/26/1996
|
Current Assignee
Mitsubishi Electric Corporation
|
Original Assignee
Mitsubishi Electric Corporation
|
Semiconductor modulator with a .pi. shift | ||
Patent #
US 5,694,504 A
Filed 03/08/1996
|
Current Assignee
Bookham Incorporated
|
Original Assignee
Northern Telecom Limited
|
Bidirectional optical modulator having lightwave signal conservation | ||
Patent #
US 5,528,707 A
Filed 09/30/1994
|
Current Assignee
Honeywell Incorporated
|
Original Assignee
Honeywell Incorporated
|
Optical transmission system equalizer | ||
Patent #
US 5,225,922 A
Filed 11/21/1991
|
Current Assignee
American Telephone Telegraph
|
Original Assignee
ATT Inc.
|
19 Claims
-
1. An optical device for reducing crosstalk associated with a plurality of optical channels in a communication system comprising:
-
a light source for generating a light signal at a particular wavelength, said light source having a ramp-up period in which said light source does not substantially emit the light signal at the particular wavelength; and
a light modulation element coupled to said light source, said light modulation element having an “
on” and
“
off”
state such that when said light modulation element is in said “
on”
state, said light signal generated by said light source at said particular wavelength is substantially allowed to propagate along an optical transmission path, and when said light modulation element is in said “
off”
state, said light modulation element substantially prevents said light signal from propagating along said optical transmission path,said light modulation element being in the off state during the ramp-up period of said light source to substantially prevent the light signal at a wavelength other than the particular wavelength from propagating along said optical transmission path. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
a filtering element coupled to said light modulation element, said filtering element having a transmissivity characteristic as a function of wavelength, said transmissivity characteristic defining a transmission band corresponding at or near said particular wavelength; and
a control circuit coupled to said filtering element and to said light source, said control circuit receiving a portion of said light signal at or near said particular wavelength transmitted by said filtering element, said control circuit generating a control signal, based on said portion of said light signal for controlling the wavelength and power outputted by said light source.
-
-
3. The optical device in accordance with claim 2 wherein said filtering element is an in-fiber Bragg grating.
-
4. The optical device in accordance with claim 2 wherein said light modulation element is a variable attenuator.
-
5. The optical device in accordance with claim 2 further comprising an optical splitting element coupled to said transmission path, said splitting element configured to tap said portion of said light signal at or near said particular wavelength.
-
6. The optical device in accordance with claim 2 wherein said control circuit further comprises a photodetector for receiving said portion of said optical signal and generating an electrical signal in response thereto.
-
7. The optical device in accordance with claim 6 wherein said control circuit comprises a processor for receiving and processing said electrical signal.
-
8. The optical device in accordance with claim 1 wherein said light modulation element is an electroabsorption modulator.
-
9. The optical device in accordance with claim 8 wherein said electroabsorption modulator and said light source are monolithically integrated.
-
10. The optical device in accordance with claim 1 wherein said light source is a distributed feedback laser.
-
11. An optical communication system comprising:
-
a light source generating a light signal at or near a particular wavelength when said light source is in a stabilized condition and at other wavelengths when said light source is not in the stabilized condition;
a modulation element optically communicating with said light source along a transmission path, said modulation element having a transmit condition and a nontransmit condition, wherein when said light source is in the stabilized condition said modulation element is in said transmit condition such that said light signal generated by said light source is allowed to propagate along said transmission path, and wherein when said light source is not in the stabilized condition said modulation element is in said nontransmit condition such that said modulation element substantially prevents said light signal at one of the other wavelengths from leaking into said optical transmission path;
a partially reflective element optically communicating with said modulation element; and
a control circuit optically communicating with said partially reflective element and said light source, said control circuit configured to detect a portion of said light transmitted through said partially reflective element and generating an output signal in response thereto, said output signal used to adjust said wavelength of said light signal. - View Dependent Claims (12, 13, 14, 15, 16, 17, 18, 19)
a second light source generating a second light signal at or near a second particular wavelength;
a second modulation element optically communicating with said second light source along a second transmission path, said second modulation element having a transmit condition and a nontransmit condition such that when said second modulation element is in said transmit condition, said second light signal generated by said second light source is allowed to propagate along said second transmission path, and when said second modulation element is in said nontransmit condition, said second modulation element prevents said second light source from leaking into said second optical transmission path;
a second partially reflective element optically communicating with said second modulation element; and
a second control circuit optically communicating with said second partially reflective element and said second light source, said second control circuit configured to detect a second portion of said second light transmitted through said second partially reflective element and generating an output signal in response thereto, said output signal used to adjust said second wavelength of said second light signal.
-
-
16. The optical device in accordance with claim 15 wherein said first and second transmission paths optically communicating with an optical multiplexer configured to supply said first and second optical signals to an optical waveguide.
-
17. The optical device in accordance with claim 16 wherein said first light signal transmitted by said first modulation element at said first wavelength and said second light signal transmitted by said second modulation element at said second wavelength are such that said first signal at said first wavelength does not cause crosstalk with said second signal at said second wavelength along said optical waveguide.
-
18. The optical device in accordance with claim 15 wherein said second modulation element is a semiconductor electroabsorption modulator.
-
19. The optical device in accordance with claim 15 wherein said second partially reflective element is a Bragg grating.
1 Specification
The present invention generally relates to optical communication systems and more particularly to an apparatus for providing a crosstalk-free signal source for dense wavelength division multiplexed communication systems.
Wavelength division multiplexing (WDM) is a technique for increasing the capacity of existing fiber optic networks. In a WDM system, plural optical channels are carried over a single waveguide, each channel being assigned a particular wavelength. Through the use of optical amplifiers, such as rare earth doped fiber amplifiers, these optical channels are directly amplified simultaneously, facilitating the use of WDM systems in long-distance optical networks. Dense WDM or DWDM systems are also employed which have a greater number of optical channels with smaller channel spacings.
The transmitters used in WDM systems typically include semiconductor lasers, for example Distributed Feedback lasers (DFB), where each laser transmits light at a designated one of a plurality of wavelengths. DFB lasers generally comprise one or more III-V semiconductor materials and are commercially available. Each laser outputs an optical carrier signal at a particular channel wavelength usually within the 1.55 μm range which corresponds to an absorption minimum associated with silica-based fibers.
When a laser transmitter used in a WDM system is first turned on, it experiences a “ramp-up period” where the drive current must first increase to a level where the semiconductor laser provides light at the desired wavelength and at operating power. During this ramp-up period, the laser transmitter is not yet emitting light at the desired wavelength, however light still propagates down the transmission fiber. In addition, during transmitter operation, the laser output may drift off-channel allowing unwanted light to propagate down the fiber. In either case, this unwanted light transmission may adversely impact adjacent channel performance and compromise the integrity of the transmitted information signals.
To control the output power and frequency of each laser in a WDM system, a laser controller is used to provide the required laser bias current as well as thermal control of the laser. By using thermal control which can be responsive to feedback information from a wavelength reference, the temperature of the laser diode can be adjusted so that the reference signal remains stable or at a peak, thereby maintaining the precise operating frequency of the laser.
In order to achieve high bit-rate transmission over long distances, the DFB laser sources used in DWDM communication systems are modulated externally with an information signal. This is because externally modulated DFB lasers have relatively low wavelength chirp as compared with laser diodes being directly modulated. An exemplary external modulator, such as a Mach-Zehnder modulator, employs a waveguide medium, whose refractive index changes according to the applied electrical field, i.e., the refractive index of an electro-optic material such as LiNbO3 can be changed by applying an external voltage. In a Mach-Zehnder configuration, two optical interferometer paths are provided where an incoming optical carrier is split between the two paths. In the absence of an external voltage, the optical fields in the two paths constructively interfere. When an external voltage is applied, the refractive index in the waveguides is altered which induces a phase shift that produces destructive interference at its output.
When a LiNbO3 modulator is employed with a semiconductor light source in a WDM system, it would be advantageous to turn the modulator off in order to prevent the transmission of unwanted light from propagating down the optical fiber. Once the drive current would increase to a level where the laser provides light at the desired channel wavelength at the operating power, the modulator may be modulated to produce the desired information signals. However, LiNbO3 modulators without attenuators retain an unwanted electrostatic charge in the off-state which distorts the output signal which may then propagate down the transmission fiber and cause bit errors at the receiving end.
This can be seen with reference to FIG. 1 which represents a digital bit stream of ones and zeros modulated by a typical LiNbO3 modulator. A true “on” state representing a one bit corresponds to a voltage level of VON and a true “off” state representing a zero bit corresponds to a voltage level of VOFF. As stated above, a LiNbO3 modulator retains an unwanted electrostatic charge such that the voltage level in the “off” state corresponds to V0. Similarly, when the LiNbO3 modulator is in the “on” state, the voltage level corresponds to V1. In other words, this retained charge produces a voltage level which distorts the output signal representing a one or a zero in the digital bit stream which may cause bit errors at the receiving end, thereby compromising signal integrity.
Thus, there is a need to provide a simple and cost effective optical device which provides a crosstalk-free signal source for multiple wavelength optical transmission systems.
The present invention meets these needs and avoids the above-referenced drawbacks by providing an optical device to stabilize the output frequency of a laser transmitter and insuring the integrity of the modulated signal. The optical device in accordance with the present invention includes a light source for generating a light signal at a particular wavelength and a light modulation element coupled to the light source. The light modulation element has an associated “on” and “off” state such that when the light modulation element is in the “on” state, the light signal generated by the light source at the particular frequency is allowed to propagate along an optical transmission path, and when the light modulation element is in the “off” state, the light modulation element prevents light from propagating along the optical transmission path.
The optical device in accordance with the present invention also includes a filtering element coupled to the light modulation element. The filtering element has a transmissivity characteristic as a function of wavelength which defines a transmission band corresponding at or near the particular wavelength. A control circuit is also included which is coupled to the filtering element and to the light source. The control circuit receives a portion of the light signal at or near the particular wavelength transmitted by the filtering element. The control circuit generates a control signal, based on a portion of the light signal, for controlling the output power and temperature of the light source.
The foregoing, and other features and advantages of the present invention, will be apparent from the following description, the accompanying drawings and the appended claims.
FIG. 1 represents a digital bit stream of ones and zeros modulated by a typical LiNbO3 modulator
FIG. 2 is a schematic illustration of an optical device in accordance with the present invention.
FIG. 3 illustrates output power of a typical electroabsorption modulator as a function of the reverse bias applied to the modulator
FIG. 4 illustrates the transmittance vs. wavelength characteristic of an exemplary filtering element in accordance with the present invention.
FIG. 5 is a schematic illustration of a transmission system employing a plurality of optical devices described with reference to FIG. 2.
In accordance with the present invention, an optical device is described which provides a crosstalk-free signal source for wavelength division multiplexed systems. A filtering element is used for providing a portion of an optical signal to a control circuit used to lock the output of the signal source.
FIG. 2 schematically illustrates an optical device 10 in accordance with the present invention wherein light source 20 is coupled to the input of a light modulation element 30 along transmission path 25. Device 10 can be, for example, a transmitter for a particular channel frequency within a wavelength division multiplexed (WDM) or dense WDM communication system. Light source 20 can be, for example, a DFB semiconductor diode laser generally comprising one or more III-V semiconductor materials commercially available. The laser light source outputs an optical carrier signal at a particular channel wavelength typically in the 1550 nm range.
Light source 20 is coupled to light modulation element 30 by way of optical transmission path 25 which is typically a single-mode silica-based fiber with an absorption minimum in the 1550 nm range. However, any optical waveguide which is capable of transporting an optical channel can be employed as transmission path 25. Alternatively, light source 20 and light modulation element 30 are monolithically integrated, thereby alleviating the need for transmission path 25 disposed between light source 20 and light modulation element 30.
Light modulation element 30 can be, for example, a semiconductor electroabsorption (“EA”) modulator formed on an InP substrate used to modulate light generated by source 20 with information signals. Among different types of optical modulators, semiconductor electro-absorption modulators consisting of III/V compound semiconductors are promising candidates for optical communication system. This type of external modulator is based on large field-induced variations in absorption coefficient due to either the Franz-Keldysh effect in double heterostructure, or the quantum confined Stark effect in multiple quantum-well structure. The modulators can be easily integrated monolithically with semiconductor lasers by using butt-coupling, selective area growth, vertical-mode coupling or quantum-well interdiffusion techniques to realize compact and stable sources for data transmission. FIG. 3 illustrates output power of a typical EA modulator as a function of the reverse bias applied to the modulator. As can be seen, more than 20 dB attenuation can be obtained at 3.5 volts reverse bias.
Generally, an EA modulator is configured such that when the modulator is in the “off” state, light from source 20 does not propagate down fiber 25. This is advantageous when light source 20 is in the ramp-up stage i.e. where light source 20 is first turned on and the drive current has not reached the associated level where the source produces light at the desired wavelength and at peak power. During this ramp-up period, light modulation element 30 is in the “off” state, thereby preventing light produced by source 20 from propagating down fiber 25. Once the laser generates light at the desired output wavelength, the laser is locked by control circuitry 50 as described in more detail below. In other words, the light modulation element 30 is biased “off” while laser 20 stabilizes to the desired output power and operating frquency.
A splitter 35, for example a 95/5 tap, is coupled to transmission path 25 to direct a small percentage of the signals output by light modulation element 30 to filtering element 40. In this manner, a portion of the modulated signal is used to control the output of light source 20, as described below, and the majority of the modulated signal propagates along transmission path 25. Exemplary optical splitters include 1×N wideband single mode and fused fiber splitters, both of which are commercially available.
A filtering element 40 is coupled along path 25 and is configured to transmit the desired signal wavelength and reflect wavelengths outside the transmission band. In an exemplary embodiment, filtering element 40 can be a Bragg grating comprising a series of photoinduced refractive index perturbations in an optical fiber which reflects optical signals within a selected wavelength band and transmits wavelengths outside of the selected wavelength band. Bragg gratings suitable for use in the optical system in accordance with the present invention are described in, for example, Morey et al., “Photoinduced Bragg Gratings in Optical Fibers,” Optics and Photonics News, February 1994, pp. 8-14.
FIG. 4 illustrates a transmission characteristic 65 of an exemplary Bragg grating as filtering element 40 which is relatively high for wavelengths greater than or less than a particular operating wavelength λ0 generated by light source 20. During the ramp-up period for light source 20, light modulation element 30 is turned off preventing wavelengths outside the operating wavelength from reaching filtering element 40 via coupler 35. Once the operating current of light source 20 is reached, thereby producing a signal at the desired wavelength, light modulation element 30 is turned “on” and the output of source 20 is modulated with an information signal. The output wavelength of light source 20 may still vary depending on, for example, variations in laser bias current and/or the temperature of light source 20. However, these variations are typically close to λ0, i.e. within portion 60 of transmissivity curve 65, and most of the light received by grating 40 is reflected back to transmission path 25 via splitter 35. The portion of the light which is transmitted by filtering element 40 is supplied to control circuitry 50.
Control circuitry 50 is coupled to light source 20 and is used to control the output wavelength and power of the light source based on a portion of the signal output by light modulation element 30 via tap 35 and grating 40. For example, where light source 20 is a semiconductor laser, circuitry 50 generates output signals which control the temperature control current supplied to the laser, thereby adjusting the output of the laser to remain within portion 75 of transmissivity curve 65 shown in FIG. 2. Control circuitry 50 can include hardware and/or software configurations. Typically, control circuitry 50 can include one or more photodetectors for receiving the transmitted signals from filtering element 40. The photodetectors generate electrical signals in response to these received optical signals which are then used to control the output of light source 20. Examples of these types of control circuitry are included in application Ser. No. 08/848,423 entitled “Laser Wavelength Control Device” assigned to the assignee of the present invention and an application entitled “Laser Wavelength Control Under Direct Modulation” filed on Jul. 22, 1997 (Ser. No. 08/898,714) also assigned to the assignee of the present invention, both of which are incorporated herein by reference. In this manner, filtering element 40 and control circuit 50 are used to lock the output wavelength and power of light source 20.
FIG. 5 illustrates a simplified optical communication system 100 in which a plurality of optical devices 101. . . 10N are used to provide optical signals at particular wavelengths modulated with information for transmission over an optical fiber. As described above with reference to FIGS. 1 and 2, each optical device 101. . . 10N is configured to supply a modulated optical channel to transmission paths 251. . . 25N, respectively. Each optical channel carries information at an associated data rate and particular wavelength with appropriate frequency spacings, for example 100, 50, 25 GHz therebetween. Mulitplexer 110 can be an N×1 or N×2 (for protection switching) multiplexer configured to receive the plurality of optical channels and output a wavelength division multiplexed optical signal onto transmission path 120. Typically, when optical transmission path 120 is used as a long-haul carrier route, transmission path 120 is on the order of hundreds of kilometers long with optical amplifiers spaced approximately every one hundred kilometers, with a range of 30-130 kilometers being exemplary. Transmission path 120 is coupled to demultiplexer 130 used to separate the received multiplexed signal and supply the respective optical channels to N receiving units 1401. . . 140N via transmission lines 1501. . . 150N, respectively. By employing optical devices 101. . . 10N at the transmitting end of system 100 and biasing “off” the respective light modulation elements until the laser sources stabilize, crosstalk between channels within the multiplexed signal is reduced.
While the foregoing invention has been described in terms of the embodiments discussed above, numerous variations are possible. Accordingly, modifications and changes such as those suggested above, but not limited thereto, are considered to be within the scope of the following claims.